AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas Pharmaceutical Investing
BOTOX® Cosmetic Continues its Mission of Empowering Entrepreneurs Through "The Confidence Project" Pharmaceutical Investing
Pfizer's Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer Pharmaceutical Investing
AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE for the Treatment of Glabellar Lines Pharmaceutical Investing
